{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T19:58:41Z","timestamp":1760644721890},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.jim.2003.09.015","type":"journal-article","created":{"date-parts":[[2003,11,8]],"date-time":"2003-11-08T12:13:10Z","timestamp":1068293590000},"page":"247-259","source":"Crossref","is-referenced-by-count":11,"title":["Direct isolation of recombinant human antibodies against group B Neisseria meningitidis from scFv expression libraries"],"prefix":"10.1016","volume":"283","author":[{"given":"John Erik","family":"Stacy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Kausmally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f8rg","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silje H.","family":"Nordgard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Als\u00f8e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terje E.","family":"Michaelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Henrik","family":"Brekke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2003.09.015_BIB1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-3083.1998.00319.x","article-title":"Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine","volume":"47","author":"Aase","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jim.2003.09.015_BIB2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/bja\/90.1.72","article-title":"Severe meningococcal disease in childhood","volume":"90","author":"Baines","year":"2003","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jim.2003.09.015_BIB3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00000441-200207000-00004","article-title":"Therapeutic applications of monoclonal antibodies","volume":"324","author":"Berger","year":"2002","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jim.2003.09.015_BIB4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2003.09.015_BIB5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrd984","article-title":"Therapeutic antibodies for human diseases at the dawn of the twenty-first century","volume":"2","author":"Brekke","year":"2003","journal-title":"Nat. Rev., Drug Discov."},{"key":"10.1016\/j.jim.2003.09.015_BIB6","first-page":"7","article-title":"Separation of leukocytes from blood and bone marrow. Introduction","volume":"97","author":"Boyum","year":"1968","journal-title":"Scand. J. Clin. Lab. Invest., Suppl."},{"key":"10.1016\/j.jim.2003.09.015_BIB7","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/IAI.68.6.3200-3209.2000","article-title":"Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections","volume":"68","author":"Burnie","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2003.09.015_BIB8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1574-695X.2002.tb00589.x","article-title":"Identification of ABC transporters in vanomycin-resistant Enterococcus faecium as potential targets for antibody therapy","volume":"33","author":"Burnie","year":"2002","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.jim.2003.09.015_BIB9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jim.2003.09.015_BIB10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nbt0202-114","article-title":"Antibodies for defense against biological attack","volume":"20","author":"Casadevall","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jim.2003.09.015_BIB11","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/AAC.46.5.1340-1344.2002","article-title":"Effects of Specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of \u03b2-lactams in a mouse sepsis model","volume":"46","author":"Casal","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jim.2003.09.015_BIB12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/79494","article-title":"Antibody arrays for high-throughput screening of antibody\u2013antigen interactions","volume":"18","author":"de Wildt","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jim.2003.09.015_BIB13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/515184","article-title":"Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock","volume":"28","author":"Derkx","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jim.2003.09.015_BIB14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"13","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2003.09.015_BIB15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/341069","article-title":"Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV","volume":"186","author":"Frank","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2003.09.015_BIB16","first-page":"67","article-title":"Production, characterization and control of MenB vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Annals"},{"key":"10.1016\/j.jim.2003.09.015_BIB17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1099\/0022-1317-50-10-847","article-title":"Cytokines, chemokines and other molecules involved in meningococcal disease","volume":"50","author":"Hackett","year":"2001","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.jim.2003.09.015_BIB18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-3083.2003.01255.x","article-title":"Cloning, sequencing and expression of immunoglobulin variable regions of murine monoclonal antibodies specific for the P1.7 and P1.16 PorA protein loops of Neisseria meningitidis","volume":"57","author":"Ihle","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jim.2003.09.015_BIB19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0022-1759(96)00115-9","article-title":"Rapid detection of antibody fragments against cell-surface antigens by flow cytometry","volume":"196","author":"Kipriyanov","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2003.09.015_BIB20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jmbi.1999.3444","article-title":"Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides","volume":"296","author":"Knappik","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jim.2003.09.015_BIB21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/517385","article-title":"New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4","volume":"177","author":"Martin","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2003.09.015_BIB22","first-page":"165","article-title":"Meningococcal disease: treatable but still terrifying Intern","volume":"32","author":"Munro","year":"2002","journal-title":"Med. J."},{"key":"10.1016\/j.jim.2003.09.015_BIB23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0264-410X(98)00259-X","article-title":"Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunisation with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine","volume":"17","author":"N\u00e6ss","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2003.09.015_BIB24","series-title":"Abstracts: 13th International Pathogenic Neisseria Conference, Oslo, Nordberg Aksidenstrykkeri AS, Oslo","first-page":"284","article-title":"Immunogenicity of a combination of two different outer membrane protein based meningococcal group B vaccines","author":"N\u00e6ss","year":"2002"},{"key":"10.1016\/j.jim.2003.09.015_BIB25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(97)00034-3","article-title":"Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells","volume":"204","author":"Norderhaug","year":"1997","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2003.09.015_BIB26","first-page":"485","article-title":"Cost-utility analysis of patient care in children with meningeal signs","volume":"18","author":"Oostenbrink","year":"2002","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"10.1016\/j.jim.2003.09.015_BIB27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1380-2933(97)10004-5","article-title":"A definitive set of oligonucleotide primers for amplifying human V regions","volume":"3","author":"Sblattero","year":"1998","journal-title":"Immunotechnology"},{"issue":"Suppl. 2","key":"10.1016\/j.jim.2003.09.015_BIB28","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/344939","article-title":"Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury","author":"Scheld","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2003.09.015_BIB29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0003-2697(91)90131-C","article-title":"Filter screening of antibody Fab fragments secreted from individual bacterial colonies: specific detection of antigen binding with a two-membrane system","volume":"196","author":"Skerra","year":"1991","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jim.2003.09.015_BIB30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11908-002-0004-4","article-title":"Pathogenesis, therapy and prevention of meningococcal sepsis","volume":"4","author":"Stephens","year":"2002","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.jim.2003.09.015_BIB31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/CMR.13.1.144-166.2000","article-title":"Update on meningococcal disease with emphasis on pathogenesis and clinical management","volume":"13","author":"van Deuren","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jim.2003.09.015_BIB32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00063030-200216050-00001","article-title":"Meningococcal vaccines: a progress report","volume":"16","author":"Wildes","year":"2002","journal-title":"BioDrugs"},{"key":"10.1016\/j.jim.2003.09.015_BIB33","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunological response in man to group B meningococcal polysaccharide vaccines","volume":"126","author":"Wyle","year":"1972","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175903003971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175903003971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T07:50:51Z","timestamp":1550389851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175903003971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0022175903003971"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2003.09.015","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}